contract HDTRA114C0115 Definitive Contract
DOD Defense Threat Reduction Agency
$5m
Mapp Biopharmaceutical, Inc. Definitive Contract
- Last active 5 months ago
Contract # HDTRA114C0115
PSC AN12 R&d- Medical: Biomedical (Appl...
Set-Aside None
Status Fully Executed
POP 6/10/14 - 6/9/19 (4 years)
-
- $5m Dollars Obligated
- $7.7m Base & Exercised Options
- $7.7m Base & All Options (Ceiling)
- Cost Plus Fixed Fee Pricing Type
- Partially Funded Funding Status
- Full and Open Competition, 8 offer(s) Extent Competed
-
Description
BASE PERIOD - PSC: AN12 RESEARCH AND DEVELOPMENT SERVICES
-
Agency
-
Office
-
Awarded Vendor
-
Contact(s)
Not Provided
-
Project(s)
Not Provided
| Amount | Date | Reason For Modification | |
|---|---|---|---|
| $200k | 2/8/18 | Exercise An Option | |
| EBOLA BOX OPTION PERIOD TWO - PSC: AN12 | |||
| -- | 10/30/17 | Supplemental Agreement For Work Within Scope | |
| RESEARCH AND DEVELOPMENT SERVICES | |||
| -- | 5/24/17 | Supplemental Agreement For Work Within Scope | |
| NO COST EXTENSION TO OP1 | |||
| $1.1m | 1/12/17 | Funding Only Action | |
| INCREMENTAL FUNDING | |||
| $1.1m | 5/27/16 | Exercise An Option | |
| OPTION PERIOD I - PSC: AN12 | |||
| -- | 11/24/15 | Supplemental Agreement For Work Within Scope | |
| BASE PERIOD - PSC: AN12 | |||
| -- | 5/20/15 | Supplemental Agreement For Work Within Scope | |
| BASE PERIOD - PSC: AN12 | |||
| $2.5m | 6/10/14 | Not Listed | |
| BASE PERIOD - PSC: AN12 RESEARCH AND DEVELOPMENT SERVICES | |||